pd 142893 has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, XF; Shimoni, Y | 1 |
| Benigni, A; Bertani, T; Brena, C; Bruzzi, I; Colosio, V; Remuzzi, G | 1 |
2 other study(ies) available for pd 142893 and Alloxan Diabetes
| Article | Year |
|---|---|
Role of PKC in autocrine regulation of rat ventricular K+ currents by angiotensin and endothelin.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Blotting, Western; Diabetes Mellitus, Experimental; Diglycerides; Electric Conductivity; Endothelin Receptor Antagonists; Endothelins; Enzyme Activation; Enzyme Inhibitors; Heart; Heart Ventricles; Homeostasis; Hypothyroidism; Isoquinolines; Male; Oligopeptides; Potassium Channels; Potassium Channels, Voltage-Gated; Protein Kinase C; Protein Kinase C-epsilon; Quinapril; Rats; Rats, Sprague-Dawley; Saralasin; Shal Potassium Channels; Tetrahydroisoquinolines; Thyroidectomy | 2003 |
Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cohort Studies; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Follow-Up Studies; In Situ Hybridization; Kidney; Lisinopril; Male; Oligopeptides; Pilot Projects; Proteinuria; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors | 1998 |